Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1957 1
1959 1
1962 1
1963 5
1964 13
1965 4
1966 2
1967 3
1968 4
1969 6
1970 6
1971 6
1972 12
1973 7
1974 9
1975 10
1976 6
1977 6
1978 13
1979 12
1980 13
1981 10
1982 17
1983 12
1984 21
1985 14
1986 17
1987 7
1988 8
1989 14
1990 17
1991 25
1992 18
1993 34
1994 26
1995 19
1996 13
1997 13
1998 13
1999 26
2000 22
2001 14
2002 19
2003 15
2004 15
2005 16
2006 13
2007 17
2008 19
2009 14
2010 15
2011 16
2012 16
2013 15
2014 26
2015 24
2016 22
2017 28
2018 14
2019 28
2020 28
2021 18
2022 19
2023 17
2024 21
2025 24
2026 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

938 results

Results by year

Filters applied: . Clear all
Page 1
Drug-induced immune neutropenia/agranulocytosis.
Curtis BR. Curtis BR. Immunohematology. 2014;30(2):95-101. Immunohematology. 2014. PMID: 25247619 Review.
Reduction in neutrophils below an absolute count of 500 cells/pL is termed severe neutropenia or agranulocytosis. Drug-induced immune neutropenia (DIIN) occurs when drug-dependent antibodies form against neutrophil membrane glycoproteins and cause neutrophil …
Reduction in neutrophils below an absolute count of 500 cells/pL is termed severe neutropenia or agranulocytosis. Drug-indu
[Drug-induced agranulocytosis].
Lhomme F, Ochmann M, Lamy T. Lhomme F, et al. Rev Prat. 2015 May;65(5):697-700. Rev Prat. 2015. PMID: 26165115 Review. French. No abstract available.
Drug-induced agranulocytosis.
Young GA, Vincent PC. Young GA, et al. Clin Haematol. 1980 Oct;9(3):483-504. Clin Haematol. 1980. PMID: 7004683 Review.
Drug-induced agranulocytosis is relatively rare. It is a heterogeneous disorder in pathogenetic terms, not surprisingly in view of its idosyncratic nature. ...Any drug is potentially capable of toxicity and should be viewed with suspicion in the appropriate c
Drug-induced agranulocytosis is relatively rare. It is a heterogeneous disorder in pathogenetic terms, not surprisingly
Drug-induced neutropenia.
[No authors listed] [No authors listed] Lancet. 1983 Apr 16;1(8329):857-8. Lancet. 1983. PMID: 6132184 No abstract available.
Drug-induced agranulocytosis.
[No authors listed] [No authors listed] Drug Ther Bull. 1997 Jul;35(7):49-52. doi: 10.1136/dtb.1997.35749. Drug Ther Bull. 1997. PMID: 9282424 Review.
Drug-induced agranulocytosis is a rare, potentially fatal idiosyncratic reaction that can occur unpredictably with a wide variety of drugs when taken in a conventional dose. ...We do not consider the dose-related granulocytopenia that commonly complica
Drug-induced agranulocytosis is a rare, potentially fatal idiosyncratic reaction that can occur unpredictably with a wi
[Idiosyncratic drug-induced agranulocytosis].
Andrès E, Maloisel F; Groupe d'Etude des Agranulocytoses Médicamenteuses des Hôpitaux Universitaires de Strasbourg. Andrès E, et al. Rev Med Interne. 2006 Mar;27(3):209-14. doi: 10.1016/j.revmed.2005.06.008. Epub 2005 Jul 25. Rev Med Interne. 2006. PMID: 16043267 Review. French.
CURRENT DATA: Idiosyncratic drug-induced agranulocytosis is characterized by a neutrophil count <0.5x10(9)/l, in serious forms <0,1x10(9)/l that currently occurs especially in association with antibiotics, antithyroid drugs ant ticlopidine (>60% of t …
CURRENT DATA: Idiosyncratic drug-induced agranulocytosis is characterized by a neutrophil count <0.5x10(9)/l, in ser …
Drug-induced agranulocytosis.
Pisciotta V. Pisciotta V. Drugs. 1978 Feb;15(2):132-43. doi: 10.2165/00003495-197815020-00003. Drugs. 1978. PMID: 342230 Review.
A third type involves development of agranulocytosis following a latent period during which a sensitive patient is treated with large amounts of chlorpromazine. ...
A third type involves development of agranulocytosis following a latent period during which a sensitive patient is treated with large …
Drug-induced agranulocytosis.
Heimpel H. Heimpel H. Med Toxicol Adverse Drug Exp. 1988 Nov-Dec;3(6):449-62. doi: 10.1007/BF03259896. Med Toxicol Adverse Drug Exp. 1988. PMID: 3063921 Review.
Agranulocytosis is a rare but potentially serious adverse side effect of many drugs. Although it was recognised as an idiosyncratic type of drug reaction more than 50 years ago, its pathogenesis is still not fully understood. ...The quantification of the incidence of poten
Agranulocytosis is a rare but potentially serious adverse side effect of many drugs. Although it was recognised as an idiosyncratic t
Drug-induced agranulocytosis.
Pisciotta AV. Pisciotta AV. Haematologica. 1982 Apr;67(2):292-318. Haematologica. 1982. PMID: 6807778 Review. No abstract available.
Drug-induced blood disorders.
Danielson DA, Douglas SW 3rd, Herzog P, Jick H, Porter JB. Danielson DA, et al. JAMA. 1984 Dec 21;252(23):3257-60. JAMA. 1984. PMID: 6151006
A case-history study of drug-induced blood disorders (pancytopenia, hemolytic anemia, thrombocytopenia, and granulocytopenia) was carried out at the Group Health Cooperative of Puget Sound, a health maintenance organization with more than 200,000 members, for …
A case-history study of drug-induced blood disorders (pancytopenia, hemolytic anemia, thrombocytopenia, and granulocytopeni
938 results